Two Sigma Investments, LP Corvus Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

  • $41.1 Billion
  • Q2 2024

A detailed history of Two Sigma Investments, LP transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 47,786 shares of CRVS stock, worth $250,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,786
Previous 102,449 53.36%
Holding current value
$250,398
Previous $182,000 52.75%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.36 - $2.29 $74,341 - $125,178
-54,663 Reduced 53.36%
47,786 $86,000
Q1 2024

May 15, 2024
SELL
$1.76 - $2.41 $137,728 - $188,594
-78,255 Reduced 43.31%
102,449 $182,000
Q4 2023

Feb 14, 2024
SELL
$1.08 - $1.92 $99,687 - $177,221
-92,303 Reduced 33.81%
180,704 $318,000
Q3 2023

Nov 14, 2023
BUY
$1.41 - $2.97 $26,441 - $55,696
18,753 Added 7.38%
273,007 $398,000
Q2 2023

Aug 14, 2023
BUY
$1.0 - $3.86 $50,207 - $193,799
50,207 Added 24.61%
254,254 $582,000
Q1 2023

May 15, 2023
SELL
$0.65 - $0.92 $50,141 - $70,968
-77,140 Reduced 27.43%
204,047 $185,000
Q4 2022

Feb 14, 2023
SELL
$0.74 - $1.04 $109,905 - $154,461
-148,521 Reduced 34.56%
281,187 $239,000
Q3 2022

Nov 14, 2022
BUY
$0.71 - $1.17 $48,758 - $80,348
68,674 Added 19.02%
429,708 $352,000
Q2 2022

Aug 15, 2022
SELL
$0.87 - $2.03 $124,515 - $290,535
-143,121 Reduced 28.39%
361,034 $357,000
Q1 2022

May 16, 2022
SELL
$1.46 - $2.48 $622,386 - $1.06 Million
-426,292 Reduced 45.82%
504,155 $827,000
Q4 2021

Feb 14, 2022
BUY
$2.34 - $5.31 $1.85 Million - $4.19 Million
789,992 Added 562.45%
930,447 $2.24 Million
Q3 2021

Nov 15, 2021
SELL
$1.89 - $8.53 $319,784 - $1.44 Million
-169,198 Reduced 54.64%
140,455 $680,000
Q2 2021

Aug 16, 2021
SELL
$2.46 - $3.14 $96,193 - $122,783
-39,103 Reduced 11.21%
309,653 $827,000
Q1 2021

May 17, 2021
BUY
$2.86 - $4.77 $997,442 - $1.66 Million
348,756 New
348,756 $1.07 Million
Q3 2020

Nov 16, 2020
SELL
$2.6 - $5.37 $132,017 - $272,667
-50,776 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$2.01 - $4.05 $97,448 - $196,352
-48,482 Reduced 48.84%
50,776 $138,000
Q1 2020

May 15, 2020
SELL
$1.74 - $5.98 $16,253 - $55,859
-9,341 Reduced 8.6%
99,258 $209,000
Q4 2019

Feb 14, 2020
BUY
$2.56 - $5.44 $114,050 - $242,357
44,551 Added 69.56%
108,599 $591,000
Q3 2019

Nov 14, 2019
BUY
$3.01 - $6.5 $51,603 - $111,436
17,144 Added 36.55%
64,048 $193,000
Q2 2019

Aug 14, 2019
SELL
$3.3 - $4.58 $55,958 - $77,663
-16,957 Reduced 26.55%
46,904 $175,000
Q1 2019

May 15, 2019
SELL
$3.75 - $4.97 $18,146 - $24,049
-4,839 Reduced 7.04%
63,861 $257,000
Q4 2018

Feb 14, 2019
BUY
$3.29 - $8.94 $226,023 - $614,178
68,700 New
68,700 $252,000

Others Institutions Holding CRVS

# of Institutions
52
Shares Held
28M
Call Options Held
22.9K
Put Options Held
29.8K
View Full List

About Corvus Pharmaceuticals, Inc.

CRVS Quotes by TradingView
  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $244M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email